Choice without compromise.

Soa 2 delivers automated, objective, and accurate results across a growing menu of assays from respiratory infectious diseases to Lyme disease and GI infections. With its unique “Advance Result Technology” (ART), Soa 2 can provide results in as few as 3 minutes, helping you get through increasingly heavier workloads.

With Soa 2, you no longer have to choose between accuracy and speed.

For more information, contact Quidel Inside Sales at 858.431.5814. 2326

*THESE TESTS ARE AVAILABLE FOR SALE IN THE USA UNDER EMERGENCY USE AUTHORIZATION. These tests have authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories viruses or pathogens. These assays are only authorized for the duration of the declaration that vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of authorization is terminated or revoked sooner.

2327